Aileron Therapeutics Analysis

ALRNDelisted Stock  USD 2.11  0.15  7.65%   
Aileron Therapeutics is overvalued with Real Value of 2.0 and Hype Value of 2.18. The main objective of Aileron Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Aileron Therapeutics is worth, separate from its market price. There are two main types of Aileron Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Aileron Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Aileron Therapeutics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Aileron Stock trading window is adjusted to America/New York timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Aileron Stock Analysis Notes

About 28.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.91. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aileron Therapeutics recorded a loss per share of 2.88. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 11th of November 2022. Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts. Aileron Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. For more info on Aileron Therapeutics please contact the company at 737 802 1989 or go to https://www.aileronrx.com.

Aileron Therapeutics Investment Alerts

Aileron Therapeutics is now traded under the symbol RNTX. Please update your portfolios or report it if you believe this is an error. Report It!
Aileron Therapeutics is not yet fully synchronised with the market data
Aileron Therapeutics generated a negative expected return over the last 90 days
Aileron Therapeutics has high historical volatility and very poor performance
Aileron Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (15.73 M) with loss before overhead, payroll, taxes, and interest of (17.01 M).
Aileron Therapeutics currently holds about 32.38 M in cash with (19.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36.
Latest headline from seekingalpha.com: Aileron Therapeutics announces rebranding to Rein Therapeutics

Aileron Therapeutics Upcoming and Recent Events

Earnings reports are used by Aileron Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
18th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
18th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Aileron Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.72 M.

Aileron Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aileron Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aileron Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aileron Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
James Windsor over a month ago
Acquisition by James Windsor of 161 shares of Aileron Therapeutics at 2.25 subject to Rule 16b-3
 
James Windsor over a month ago
Acquisition by James Windsor of 517500 shares of Aileron Therapeutics at 2.85 subject to Rule 16b-3
 
University Of Texas/texas Am Investment Management Co over two months ago
Disposition of 337 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 4.28 subject to Rule 16b-3
 
University Of Texas/texas Am Investment Management Co over two months ago
Disposition of 6291 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 3.3 subject to Rule 16b-3
 
Musso Alan A over three months ago
Disposition of 17064 shares by Musso Alan A of Aileron Therapeutics at 4.63 subject to Rule 16b-3
 
Aivado Manuel over three months ago
Acquisition by Aivado Manuel of 1133000 shares of Aileron Therapeutics at 0.48 subject to Rule 16b-3
 
Fairey William over three months ago
Acquisition by Fairey William of 2725 shares of Aileron Therapeutics at 2.4 subject to Rule 16b-3
 
Wanstall Rick over three months ago
Acquisition by Wanstall Rick of 3000 shares of Aileron Therapeutics at 0.44 subject to Rule 16b-3
 
Musso Alan A over three months ago
Acquisition by Musso Alan A of 2725 shares of Aileron Therapeutics at 2.4 subject to Rule 16b-3
 
University Of Texas/texas Am Investment Management Co over three months ago
Disposition of 7923 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 4.25 subject to Rule 16b-3
 
University Of Texas/texas Am Investment Management Co over six months ago
Disposition of 4707 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 3.25 subject to Rule 16b-3
 
University Of Texas/texas Am Investment Management Co over six months ago
Disposition of 1900 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 3.3 subject to Rule 16b-3

Aileron Therapeutics Outstanding Bonds

Aileron Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aileron Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aileron bonds can be classified according to their maturity, which is the date when Aileron Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Aileron Therapeutics Predictive Daily Indicators

Aileron Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aileron Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Aileron Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aileron Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aileron shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Aileron Therapeutics. By using and applying Aileron Stock analysis, traders can create a robust methodology for identifying Aileron entry and exit points for their positions.
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts. Aileron Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Aileron Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Aileron Stock

If you are still planning to invest in Aileron Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aileron Therapeutics' history and understand the potential risks before investing.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities